Table of Content

1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Talimogene Laherparepvec
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options



List of Figures


Figure 1 The Development Timeline of Talimogene Laherparepvec
Figure 2 Patent Details, Talimogene Laherparepvec
Figure 3 Talimogene Laherparepvec, 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Talimogene Laherparepvec, US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Talimogene Laherparepvec, EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Talimogene Laherparepvec, EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Talimogene Laherparepvec, Japan Market Size from 2017 to 2030 (in Millions USD)


List of Tables


Table 1 Talimogene Laherparepvec, Description
Table 2 Talimogene Laherparepvec, Trial Diversification
Table 3 Talimogene Laherparepvec, Marketed Details United States
Table 4 Talimogene Laherparepvec, Marketed Details Europe
Table 5 Talimogene Laherparepvec, Marketed Details Japan
Table 6 Patent Details: Talimogene Laherparepvec
Table 7 Talimogene Laherparepvec, Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Talimogene Laherparepvec
Table 9 Talimogene Laherparepvec, 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Talimogene Laherparepvec, US Market Size from 2017 to 2030 (in Million USD)
Table 11 Talimogene Laherparepvec, EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Talimogene Laherparepvec, EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Talimogene Laherparepvec, Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies